From: Treatment of asthma in young children: evidence-based recommendations
NAEPP [31] | British [32] | GINA [33] | Canadian [34] | |
---|---|---|---|---|
Step 1 | SABA prn | SABA prn | SABA prn | SABA prn |
Step 2 | Pref: Low-dose ICS | Pref: ICS 200–400 μg /daya,b | Pref: Daily low-dose ICS | Pref: Daily low-dose ICS |
Alter: cromolyn or LTRA | Alter: LTRA | Alter: LTRA or intermittent ICS | Alter: LTRA | |
Step 3 | Medium-dose ICS | ICS + LTRA | Pref: Double low-dose ICS | Medium-dose ICS |
Alter: Low-dose ICS + LTRA | ||||
Step 4 | Medium-dose ICS + either LABA or LTRA | Refer to respiratory pediatrician | Pref: Continue controller & refer for specialist assessment | Referral to asthma specialist |
Alter: Add LTRA, increase ICS frequency, intermittent ICS. | ||||
Step 5 | High-dose ICS + either LABA or LTRA | |||
Step 6 | High-dose ICS + either LABA or LTRA | |||
Consider OCS |